| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/25/2001 | WO2001036635A2 Neurite outgrowth-promoting factor homologue and nucleic acids encoding same |
| 05/25/2001 | WO2001036634A1 Novel g protein-coupled receptors, genes thereof and production and use of the same |
| 05/25/2001 | WO2001036633A1 Novel protein and dna thereof |
| 05/25/2001 | WO2001036632A2 Variants of alternative splicing |
| 05/25/2001 | WO2001036631A1 Human nogo-c polynucleotide and polypeptide and their uses |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036629A1 Transfer compounds, the production and the use thereof |
| 05/25/2001 | WO2001036626A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | WO2001036621A2 Down-regulation and silencing of allergen genes in transgenic peanut seeds |
| 05/25/2001 | WO2001036619A2 Cloning and characterization of the cap gene promoter |
| 05/25/2001 | WO2001036618A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/25/2001 | WO2001036614A2 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 05/25/2001 | WO2001036601A1 Method for the preparation of purified hcv rna by exosome separation |
| 05/25/2001 | WO2001036598A1 Environmental stress tolerance genes |
| 05/25/2001 | WO2001036597A1 Plant biochemistry-related genes |
| 05/25/2001 | WO2001036596A2 Modulation of plant response to abscisic acid |
| 05/25/2001 | WO2001036595A2 Methods for conditional transgene expression and trait removal in plants |
| 05/25/2001 | WO2001036594A1 Mcl-1 GENE REGULATORY ELEMENTS AND A PRO-APOPTOTIC Mcl-1 VARIANT |
| 05/25/2001 | WO2001036588A2 Fusion proteins that specifically inhibit protein synthesis in neuronal cells |
| 05/25/2001 | WO2001036587A2 Gene for encoding merozoite surface protein of plasmodium vivax and use thereof |
| 05/25/2001 | WO2001036489A2 Erythropoietin forms with improved properties |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036486A2 Scfv antibodies against disease associated molecules |
| 05/25/2001 | WO2001036484A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | WO2001036483A1 Use of the insulin-like-growth factor i isoform mgf for the treatment of neurological disorders |
| 05/25/2001 | WO2001036482A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 05/25/2001 | WO2001036481A1 Novel chimeric g-alpha proteins displaying increased promiscuity for gpcr's |
| 05/25/2001 | WO2001036480A1 Mouse 7-transmembrane receptor, axor45 |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036478A2 Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides |
| 05/25/2001 | WO2001036477A2 Inhibition of abc transporters by transmembrane domain analogs |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036474A2 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | WO2001036473A2 Human g protein-coupled receptors |
| 05/25/2001 | WO2001036472A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036471A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | WO2001036470A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 05/25/2001 | WO2001036469A2 Human ceruloplasmin |
| 05/25/2001 | WO2001036468A2 Novel proteins having insecticidal activities and method of use |
| 05/25/2001 | WO2001036467A2 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | WO2001036466A2 Educational kit and method using colipase-like protein-1 |
| 05/25/2001 | WO2001036464A2 SUNFLOWER RhoGAP, LOX, ADH, AND SCIP-1 POLYNUCLEOTIDES AND METHODS OF USE |
| 05/25/2001 | WO2001036463A2 Genes specifically expressed in human dendritic cells |
| 05/25/2001 | WO2001036461A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036460A2 Methods and means for regulation of gene expression |
| 05/25/2001 | WO2001036459A2 Novel use of hcc-2 |
| 05/25/2001 | WO2001036458A2 Drosophila ced-6 homologue |
| 05/25/2001 | WO2001036457A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/25/2001 | WO2001036456A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/25/2001 | WO2001036455A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2001036448A2 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 05/25/2001 | WO2001036447A2 Hormone receptor functional entities and methods of their use |
| 05/25/2001 | WO2001036446A2 Use of g-protein coupled receptors (gpcrs) and modified gpcrs for the treatment of diseases |
| 05/25/2001 | WO2001036445A1 Compositions and methods for the improved diagnosis and treatment of germ cell tumors |
| 05/25/2001 | WO2001036444A1 Plant developmental genes |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036433A2 Synthetic lipid-a analogs and uses thereof |
| 05/25/2001 | WO2001036432A2 18 human secreted proteins |
| 05/25/2001 | WO2001036001A2 Interferon gamma conjugates |
| 05/25/2001 | WO2001035992A1 Recombinant chlamydia vaccine |
| 05/25/2001 | WO2001035991A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 05/25/2001 | WO2001035988A1 Use of glp-1 agonists for the inhibition of beta cell degeneration |
| 05/25/2001 | WO2001035985A1 P-superfamily conopeptides |
| 05/25/2001 | WO2001035981A1 Methods and compositions for treatment of disease |
| 05/25/2001 | WO2001035903A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001035811A2 Methods of diagnosing and determining prognosis of breast cancer |
| 05/25/2001 | WO2001035748A1 Bifunctional molecules having modulated pharmacokinetic properties and therapies based thereon |
| 05/25/2001 | WO2001035727A1 Seed trait genes |
| 05/25/2001 | WO2001035726A1 Pathogen tolerance genes |
| 05/25/2001 | WO2001035725A1 Yield-related genes |
| 05/25/2001 | WO2001018039A3 INCREASED PRODUCTION OF INTERFERON-$g(a) |
| 05/25/2001 | WO2001011085A3 Bdnf polymorphism and association with bipolar disorder |
| 05/25/2001 | WO2001011008A3 Process for obtaining and detecting gram-positive fluorescent bacteria |
| 05/25/2001 | WO2001005822A3 Molecules derived from interleukin-1 beta |
| 05/25/2001 | WO2001004314A3 Nucleic acid molecules and proteins associated with sterol synthesis and metabolism |
| 05/25/2001 | WO2001004141A3 Seripancrin |
| 05/25/2001 | WO2001000667A3 Anti-thrombin peptide from anopheles albimanus salivary gland |
| 05/25/2001 | WO2001000232A3 Use of cpg as an adjuvant for hiv vaccine |
| 05/25/2001 | WO2000078956A8 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
| 05/25/2001 | WO2000078801A3 Insulin-like growth factor agonist molecules |
| 05/25/2001 | WO2000077041A3 Peptides from decorin binding protein and their uses |
| 05/25/2001 | WO2000075278A3 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 05/25/2001 | WO2000073345A3 Antibodies specific for mycobacterial polypeptides and uses thereof |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000070024A3 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses |
| 05/25/2001 | WO2000067793A8 Death domain containing receptor 4 |
| 05/25/2001 | WO1999063087A8 G-protein coupled receptor, named 2871 receptor |
| 05/25/2001 | WO1997013866A3 Recombinant herpes virus vectors for expression in neuronal cells |
| 05/25/2001 | CA2732120A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392208A1 Fusion proteins that specifically inhibit protein synthesis in neuronal cells |
| 05/25/2001 | CA2392109A1 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2392090A1 G-protein coupled receptor |
| 05/25/2001 | CA2392065A1 Sunflower rhogap, lox, adh, and scip-1 polynucleotides and methods of use |
| 05/25/2001 | CA2392051A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 05/25/2001 | CA2392044A1 Educational kit and method using colipase-like protein-1 |